Rob Scott MD

Commander
DISC Type : D

Chief Medical Officer & Head of R&D at ABIONYX Pharma

Los Angeles Metropolitan Area, United States

Overview

Rob Scott is a seasoned pharmaceutical executive with nearly four decades of experience, currently serving as Head of R&D and CMO at ABIONYX Pharma. He has overseen the development of blockbuster drugs like Lipitor, Repatha, and Skyrizi. A University of Cape Town graduate, he sits on multiple biotech and venture capital boards.

His social media activity shows a strong interest in metabolic health, particularly the science behind LDL cholesterol management and the impact of diet on cardiovascular disease. He advocates for balanced, evidence-based health information over media fear-mongering and is described by colleagues as a visionary leader.

Unique fact: Born in Zimbabwe, he invented and developed Caduet, the first commercially available combination pill (Polypill) for cardiovascular disease.

Personality Overview

Decisive

Very Quick

Candid & Clear

They prefer to move quickly, and expect the same from others.  They do not care very much about building rapport or relationships. They respond well to strong and respectful communication.

Topics They Care About

Cardiovascular Research
A core focus of his career, he has led development for major cardiovascular drugs like Lipitor and Repatha and served on the FDA's Cardiovascular and Renal Drug Advisory Committee.
Novel Drug Development
Actively shaping the future of medicine through board and advisory roles at multiple biotech firms focused on Sepsis, rare diseases, and targeted protein degradation.
Data-Driven Clinical Trials
He created the Development Design Center at AbbVie, an excellence center focused on using predictive analytics and big data to design superior clinical trials.

Media Appearances

ABIONYX Pharma appoints Rob Scott, MD, as Chief Medical Officer and Head of R&D. Featured in PharmiWeb

See Now

ABIONYX Pharma annonce la nomination du Dr Rob Scott au poste de Chief Medical Officer et Head of R&D. Featured in Business Wire (French)

See Now

ABIONYX Pharma appoints Rob Scott, MD, as Chief Medical Officer .... Featured in ABIONYX Pharma (official press release)

See Now

Work History

1-2024
Chief Medical Officer & Head of R&D at ABIONYX Pharma
2022 - 12-2024
Board Member at Redx Pharma
1-2021
Board Member at OncoSpherix
2021 - 9-2024
Board Member at Windtree Therapeutics, Inc.
9-2020
Board Member at Draupnir Bio

Education

1977 - 1981
MbChB from University of Cape Town
1974 - 1976
BSc from University of Cape Town

More Information

Social Presence :

Prographics :

Exp : N/A Location : Los Angeles Metropolitan Area, United States Job Level : Leadership Designation : Chief Medical Officer & Head of R&D at ABIONYX Pharma
URL has been copied!

Insights For Selling To Rob

During A Call Or A Meeting

DO's

  • Use phrases like ‘it’s your decision’, ‘strategic impact’ etc.
  • Speak about competitive differentiation that your product offers
  • Objectively showcase the impact that your product creates

DONT's

  • Don’t be in a rush to invite them for a social meet and greet
  • Do not spend too much time focusing on product tech or features
  • Avoid being a storyteller and don’t try to oversell

When Cold Calling

When Writing An Email

While Negotiating & Closing

    The secret to closing fast with Rob is

  • Confidence in impact is paramount to them, followed by a sense of achievement and ROI.
  • Will you ever get a clear answer from Rob

  • If they are not convinced, they will have no hesitation in telling you the same.

Insights For Deal Planning

    How fast (or slow) will Rob move?

  • If convinced, they can reach decisions quite fast.
  • Can Rob take some risk or not?

  • They do not shy away from taking risks, but can be quite binary about them.

You And Rob

Personality Compatibility


More Profiles

Discover additional public profiles from our index.

Search more profiles

Looking for someone else? Search here for anyone.

Or visit Humantic AI to know more.